HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 1,905.00
-64.00 (-3.25%)
At close: May 11, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 86.62 billion as of May 11, 2026. Its market cap has increased by 2.91% in one year.
Market Cap
86.62B
Enterprise Value
68.45B
Revenue
15.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,905.00
Market Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 86.62B, an increase of 400.99%. That is a compound annual growth rate of 6.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 86.62B | 9.74% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 391.25B |
| 3billion | 357.00B |
| Inventera | 149.29B |
| GENINUS | 147.95B |
| Cytogen | 137.96B |
| Green Cross Medical Science | 87.40B |
| Protia | 62.07B |
| Seoulin Bioscience | 54.64B |